Health

Young-joon Park, president of the Pharmaceutical Manufacturing Innovation Society, says AI-powered digital continuous manufacturing could reduce drug production costs by 30% and defect rates by 5%, but clearer regulations and sustained government support are needed to accelerate adoption in South Korea.

Xcopri, an epilepsy medication developed by SK Biopharmaceutical, has begun domestic distribution and is now covered by South Korea’s national health insurance, potentially saving patients who previously obtained it in the United States up to $200 a month in medication costs.

GC Biopharma has signed an approximately $39.5 million agreement with Colombian vaccine company VaxThera to supply influenza vaccine bulk material and provide technical support for local production of its GC Flu vaccine.

Inventage Lab has obtained the final clinical study report for its month-long extended-release addiction treatment IVL3004, with plans to pursue further global trials, including a U.S. Phase 2 study, and explore licensing opportunities.

Samsung Biologics has secured 97.98% of Polypeptide Group’s shares through its tender offer, exceeding the 90% threshold required for a squeeze-out of remaining minority shareholders and paving the way for full ownership.